Crossmark

Zika vaccines and therapeutics: landscape analysis and challenges ahead

Crossref DOI link: https://doi.org/10.1186/s12916-018-1067-x

Published Online: 2018-06-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wilder-Smith, Annelies

Vannice, Kirsten

Durbin, Anna

Hombach, Joachim

Thomas, Stephen J.

Thevarjan, Irani

Simmons, Cameron P.
Funding

Funding for this research was provided by:

Horizon 2020 (734584)
License Information

Text and Data Mining valid from 2018-06-06
More Information

Article History

Received: 30 October 2017

Accepted: 1 May 2018

First Online: 6 June 2018

Ethics approval and consent to participate

: Not applicable.

: JH is an employee of the World Health Organization (WHO), as was KV at the time of this work. AWS is consultant to WHO. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of WHO. The authors declare no conflicts of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.